Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-80
SponsorThe Second Hospital of Anhui Medical University
About this trial
To compare the efficacy and tolerability of Electroconvulsive Therapy (ECT) and Magnetic Seizure Therapy (MST) in patients with major depressive disorder (MDD).
Eligibility criteria
Qualifiers
Aged 12-80 years;
Diagnosis confirmed by two psychiatrists per DSM-5;
Stable medication regimen pre-enrollment;
Indicated for neuromodulation OR with visual field defects.
Disqualifiers
Major systemic diseases;
Prior neuromodulation within 3 months;
Pregnancy or potential pregnancy;
Metal implants or claustrophobia.
Trial design
Treatments tested in this trial
- Electroconvulsive Therapy
- Magnetic Seizure Therapy
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov